alzheimersdisease
Blood tests for Alzheimer's disease aim to help doctors diagnose the condition more quickly and accurately but are mostly used in controlled research settings. A new Swedish study shows their reliability in real-world healthcare settings as well. The study of more than 1,200 patients experiencing mild memory symptoms found that a blood test for Alzheimer's had 90 per cent reliability in primary care. Alzheimer's can be cumbersome to diagnose, requiring a hard-to-get brain scan or an uncomfortable spinal tap. Many patients are diagnosed based on symptoms and cognitive exams. In the Swedish stud...
Euronews (English)
Researchers have developed a nasal spray that could become a breakthrough treatment for Alzheimer’s disease and other potential neurodegenerative disorders. The new treatment would target the harmful build-up of proteins in the brain. The spray works by targeting the accumulation of tau proteins, which in a healthy brain keep the cell's internal support structure stable and help transport molecules and nutrients inside nerve cells, keeping them alive. Eating meat and processed foods daily linked to Alzheimer's diseaseIn neurodegenerative disorders, chemical changes in the brain cause tau prote...
Euronews (English)
Scientists studying a family with early Alzheimer’s have found that some carry a genetic mutation that delays their initial symptoms. The hope is that this could help researchers find new ways of stopping the neurodegenerative disease if they can figure out how one copy of the very rare gene variant offers some protection. “It opens new avenues,” said Yakeel Quiroz, a neuropsychologist at Massachusetts General Hospital in the US, who helped lead the study published on Wednesday. “There are definitely opportunities to copy or mimic the effects.” Genetic protectionResearchers studying a family i...
Euronews (English)
A panel of advisers to US health regulators backed a drug to slow Alzheimer's disease on Monday setting the stage for its expected approval for patients at an early stage of the disease. The advisers voted unanimously that the drug's benefits outweighed its risks, which include side effects like brain swelling and bleeding that will have to be monitored. "I thought the evidence was very strong in the trial showing the effectiveness of the drug," said panel member Dean Follmann, a National Institutes of Health statistician. The drug, donanemab, is from pharmaceutical company Eli Lilly and has b...
Euronews (English)
In the beautifully restored main hall of the Gorton Monastery in Manchester, a man in a wheelchair starts singing ‘Danny Boy’. The man has dementia and is part of a weekly group that gives people living with the debilitating illness support through musical workshops. The man’s voice is beautiful. Timid at first, the supportive atmosphere brings him out of his shell until his deep tones echo across the monastery. The workshop is part of Music in Mind, a programme that’s been run by the Manchester Camerata in Gorton for 12 years, and is about to be rolled out for every borough in the Greater Man...
Euronews (English)
Researchers have found that people who have two copies of a specific gene almost all develop signs of Alzheimer's disease, which could represent a distinct genetic form of the condition. While scientists knew the gene APOE4 was linked to an increased risk for Alzheimer's, a new study suggests that for people carrying two copies of the gene, it's an underlying cause of it. Published in Nature Medicine, the study also found that individuals with two copies of the gene develop the disease earlier than people with other variants of the APOE gene. Alzheimer’s disease is the most common form of deme...
Euronews (English)
閲覧を続けるには、ノアドット株式会社が「プライバシーポリシー」に定める「アクセスデータ」を取得することを含む「nor.利用規約」に同意する必要があります。
「これは何?」という方はこちら